Therefore, we performed an updated meta-analysis including the most recent and relevant studies to clarify the association between ADH1B Arg47His polymorphism and the overall cancer risk, involving 66 studies with 31999 cases and 50964 controls [17–80]. The gene discussed is ADH1B; the disease is cancer.